1. 1) American Psychiatric Association: Practice Guideline for the Treatment of Patients with Delirium. APA, Washington, D. C., 1999 (Supervised Translation of the Japanese Society of Psychiatry and Neurology: American Psychiatric Association Treatment Guidelines:Delirium. Igaku Shoin, Tokyo, 2000 (in Japanese)).
2. 2) National Clinical Guideline Centre (UK). Delirium: Diagnosis, Prevention and Management. Clinical Guidelines 103, 2010.[https://www.ncbi.nlm.nih.gov/pubmed/22319805 (accessed 2018-10-10)]
3. 3) Nawata S, Kohyama N, Yamada T, Kobayashi Y, Yamamoto T. Survey of home care physicians on treatment of delirium. J Jpn Soc Pharm Palliat Care Sci. 2016; 9: 49-53. (in Japanese)
4. 4) Uchiyama M, Tanaka K, Isse K, Toru M. Efficacy of mianserin on symptoms of delirium in the aged: an open trial study. Prog Neuropsychopharmacol Biol Psychiatry. 1996; 20 (4): 651-6.
5. 5) Subcommittee for the Review of Drug Treatments. Guidelines for the Treatment of Delirium―the Japanese Society of General Hospital Psychiatry Treatment Guidelines 1―, Seiwa Shoten, Tokyo, 2005. (in Japanese)